Fungal Infection Clinical Trials

98 clinical trials for Fungal Infection across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS — RECRUITING · PHASE3
• Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score — RECRUITING
• Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial — RECRUITING · PHASE2
• PTX3-targeted Antifungal Prophylaxis — RECRUITING · NA
• Rezafungin Prophylaxis in Liver Transplant — RECRUITING · PHASE3
• Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants — RECRUITING · PHASE4
• Pharmacokinetics of fluconazole given orally or intravenously as prophylaxis or therapy to children and adolescents with invasive fungal infections (FOCUS) — OTHER · PHASE4
• IMPACT – the introduction of mycotic prophylaxis at cystectomy trial. Perioperative mycotic prophylaxis to reduce postoperative complications following cystectomy – a double-blinded, placebo-controlled, randomized trial. — TERMINATED · PHASE4
• Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE) — COMPLETED · NA
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation — COMPLETED · PHASE3
• An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection — COMPLETED
• CD5CAR-NK Cells for Refractory Invasive Mold Disease — NOT_YET_RECRUITING · PHASE1
• Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors — ACTIVE_NOT_RECRUITING
• COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) — COMPLETED
• Fungal Vascular Graft Infections, French Multicenter Retrospective Study — NOT_YET_RECRUITING
• Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects — COMPLETED · PHASE1
• Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally — COMPLETED · PHASE1
• A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection — COMPLETED · PHASE2
• Isavuconazole in Critically Ill Patients: Efficacy and Safety — NOT_YET_RECRUITING
• Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients — COMPLETED · PHASE2
• Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia — COMPLETED
• Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant — COMPLETED · PHASE3
• The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis — COMPLETED
• Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients — COMPLETED
• Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm — NOT_YET_RECRUITING · PHASE4
• Immune Profiles in CF Fungal Infection — COMPLETED
• A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 — COMPLETED · PHASE1
• A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males — COMPLETED · PHASE1
• Topical Application of Essential Oils to Treat Onchomycosis — OTHER
• Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO — OTHER
• The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital — OTHER
• Empirical Versus Preemptive Antifungal Therapy — COMPLETED · PHASE3
• Pharmacokinetics of Caspofungin — COMPLETED
• Itraconazole Oral Absorption — COMPLETED · PHASE4
• A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail — COMPLETED · PHASE2
• Vfend Special Investigation For Prophylaxis — COMPLETED
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis — COMPLETED · PHASE3
• The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock — COMPLETED
• Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole — COMPLETED · PHASE2
• The Assessment of Antimicrobial Peptides Against Fungal Infection — OTHER
• Effect of Administration of Combined Enteral Lactoferrin and Probiotic On Invasive Fungal Infections In Preterm Neonates — COMPLETED · PHASE1
• Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — OTHER · PHASE2
• Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis — COMPLETED · PHASE4
• Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases — OTHER · NA
• Safety and Pharmacokinetics of Rezafungin — TERMINATED · PHASE1
• Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin — COMPLETED · PHASE2
• Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia — COMPLETED · PHASE3
• Ampholipad Real-World Data in Taiwan — COMPLETED
• Fungal Infection in Patients in Intensive Care Units — OTHER · NA
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension — COMPLETED · PHASE2

Refine this search